Your browser doesn't support javascript.
loading
The GRAPPA-OMERACT Working Group: 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 Updates.
Leung, Ying Ying; Tillett, William; Orbai, Ana-Maria; Ogdie, Alexis; Eder, Lihi; Coates, Laura C; Holland, Richard; Antony, Anna; Goel, Niti; Mease, Philip J; Strand, Vibeke; FitzGerald, Oliver; de Wit, Maarten; Lindsay, Christine A; Callis Duffin, Kristina; Gladman, Dafna D.
  • Leung YY; From Duke-National University of Singapore (NUS) Medical School, Singapore, Department of Rheumatology and Immunology, Singapore General Hospital, Singapore; Royal National Hospital for Rheumatic Diseases, University of Bath, Bath, UK; Division of Rheumatology, Johns Hopkins University School of Med
  • Tillett W; Y.Y. Leung is funded by the Clinician Scientist award of the National Medical Research Council, Singapore (NMRC/CSA-INV/0022/2017). The views expressed are those of the author(s) and not necessarily those of the NMRC. A.M. Orbai is funded by the Jerome L. Greene Foundation Scholar Award, the Staurul
  • Orbai AM; From Duke-National University of Singapore (NUS) Medical School, Singapore, Department of Rheumatology and Immunology, Singapore General Hospital, Singapore; Royal National Hospital for Rheumatic Diseases, University of Bath, Bath, UK; Division of Rheumatology, Johns Hopkins University School of Med
  • Ogdie A; Y.Y. Leung is funded by the Clinician Scientist award of the National Medical Research Council, Singapore (NMRC/CSA-INV/0022/2017). The views expressed are those of the author(s) and not necessarily those of the NMRC. A.M. Orbai is funded by the Jerome L. Greene Foundation Scholar Award, the Staurul
  • Eder L; From Duke-National University of Singapore (NUS) Medical School, Singapore, Department of Rheumatology and Immunology, Singapore General Hospital, Singapore; Royal National Hospital for Rheumatic Diseases, University of Bath, Bath, UK; Division of Rheumatology, Johns Hopkins University School of Med
  • Coates LC; Y.Y. Leung is funded by the Clinician Scientist award of the National Medical Research Council, Singapore (NMRC/CSA-INV/0022/2017). The views expressed are those of the author(s) and not necessarily those of the NMRC. A.M. Orbai is funded by the Jerome L. Greene Foundation Scholar Award, the Staurul
  • Holland R; From Duke-National University of Singapore (NUS) Medical School, Singapore, Department of Rheumatology and Immunology, Singapore General Hospital, Singapore; Royal National Hospital for Rheumatic Diseases, University of Bath, Bath, UK; Division of Rheumatology, Johns Hopkins University School of Med
  • Antony A; Y.Y. Leung is funded by the Clinician Scientist award of the National Medical Research Council, Singapore (NMRC/CSA-INV/0022/2017). The views expressed are those of the author(s) and not necessarily those of the NMRC. A.M. Orbai is funded by the Jerome L. Greene Foundation Scholar Award, the Staurul
  • Goel N; From Duke-National University of Singapore (NUS) Medical School, Singapore, Department of Rheumatology and Immunology, Singapore General Hospital, Singapore; Royal National Hospital for Rheumatic Diseases, University of Bath, Bath, UK; Division of Rheumatology, Johns Hopkins University School of Med
  • Mease PJ; Y.Y. Leung is funded by the Clinician Scientist award of the National Medical Research Council, Singapore (NMRC/CSA-INV/0022/2017). The views expressed are those of the author(s) and not necessarily those of the NMRC. A.M. Orbai is funded by the Jerome L. Greene Foundation Scholar Award, the Staurul
  • Strand V; From Duke-National University of Singapore (NUS) Medical School, Singapore, Department of Rheumatology and Immunology, Singapore General Hospital, Singapore; Royal National Hospital for Rheumatic Diseases, University of Bath, Bath, UK; Division of Rheumatology, Johns Hopkins University School of Med
  • FitzGerald O; Y.Y. Leung is funded by the Clinician Scientist award of the National Medical Research Council, Singapore (NMRC/CSA-INV/0022/2017). The views expressed are those of the author(s) and not necessarily those of the NMRC. A.M. Orbai is funded by the Jerome L. Greene Foundation Scholar Award, the Staurul
  • de Wit M; From Duke-National University of Singapore (NUS) Medical School, Singapore, Department of Rheumatology and Immunology, Singapore General Hospital, Singapore; Royal National Hospital for Rheumatic Diseases, University of Bath, Bath, UK; Division of Rheumatology, Johns Hopkins University School of Med
  • Lindsay CA; Y.Y. Leung is funded by the Clinician Scientist award of the National Medical Research Council, Singapore (NMRC/CSA-INV/0022/2017). The views expressed are those of the author(s) and not necessarily those of the NMRC. A.M. Orbai is funded by the Jerome L. Greene Foundation Scholar Award, the Staurul
  • Callis Duffin K; From Duke-National University of Singapore (NUS) Medical School, Singapore, Department of Rheumatology and Immunology, Singapore General Hospital, Singapore; Royal National Hospital for Rheumatic Diseases, University of Bath, Bath, UK; Division of Rheumatology, Johns Hopkins University School of Med
  • Gladman DD; Y.Y. Leung is funded by the Clinician Scientist award of the National Medical Research Council, Singapore (NMRC/CSA-INV/0022/2017). The views expressed are those of the author(s) and not necessarily those of the NMRC. A.M. Orbai is funded by the Jerome L. Greene Foundation Scholar Award, the Staurul
J Rheumatol Suppl ; 96: 46-49, 2020 Jun.
Article en En | MEDLINE | ID: mdl-32482768
ABSTRACT
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)-Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) working group provided updates at the 2019 GRAPPA annual meeting on its work toward developing a core outcome set for PsA. The working group prioritized 4 domains, including musculoskeletal disease activity (enthesitis and dactylitis), fatigue, physical function, and structural damage. In this report, the working group summarizes its progress in standardizing the core outcome set for these 4 domains.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psoriasis / Artritis Psoriásica / Evaluación de Resultado en la Atención de Salud Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psoriasis / Artritis Psoriásica / Evaluación de Resultado en la Atención de Salud Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article